Timothy L Cannon
11PUBLICATIONS
69CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (11)
Sort by Publication Date:
|Oct 16, 2025
Olaparib in Patients With Solid Tumors With <i>BRCA1/2</i> Alterations: Results From The Targeted Agent and Profiling Utilization Registry (TAPUR) Study.Tareq Al Baghdadi, Michael Rothe, Pam K Mangat
|Jun 04, 2025
Real-world Data on Risk Factors for Emergency Department Visits to Treat Outpatient Chemotherapy-Associated Toxicities.Sanja Karovic, Erik Dvergsten, Chiara Pierattini
|Oct 30, 2024
Onvansertib in Combination With Chemotherapy and Bevacizumab in Second-Line Treatment of <i>KRAS</i>-Mutant Metastatic Colorectal Cancer: A Single-Arm, Phase II Trial.Daniel H Ahn, Maya Ridinger, Timothy L Cannon
|Oct 16, 2024
Palbociclib in Patients With Head and Neck Cancer and Other Tumors With <i>CDKN2A</i> Alterations: Results From the Targeted Agent and Profiling Utilization Registry Study.Francis P Worden, Evan Pisick, Michael Rothe
|May 15, 2024
Pertuzumab Plus Trastuzumab in Patients With Biliary Tract Cancer With <i>ERBB2/3</i> Alterations: Results From the Targeted Agent and Profiling Utilization Registry Study.Timothy L Cannon, Michael Rothe, Pam K Mangat
Pageof 2
Frequent Collaborators
8 joint publications
Elizabeth Garrett-Mayer
8 joint publications
Susan Halabi
8 joint publications
Richard L Schilsky
7 joint publications
Gina N Grantham
7 joint publications
Pam K Mangat
6 joint publications
Abigail Gregory
6 joint publications
Dominique C Hinshaw
5 joint publications
Ramya Thota
4 joint publications
Deepti Behl
4 joint publications
Olatunji B Alese
